ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis

Authors

Institutions

Publication Details

Journal
Trials
Published
2025-08-15
DOI
https://doi.org/10.1186/s13063-025-08973-w
Citations
2
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
2.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis

Alberto Mendoza‐Ticona, Radojka M. Savić, Rebecca G. Rogers, Kelly E. Dooley et al.
2 citations
Trials
Tuberculosis Research and Epidemiology
2.79
article

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis

Alberto Mendoza‐Ticona, Radojka M. Savić, Rebecca G. Rogers, Kelly E. Dooley, William Murtaugh, Colleen Foley, Marjorie Z. Imperial, Patrick P. J. Phillips, Shawn Chiambah, Jennifer Furin, Eunsol Yang, Justin Shenje, Salah Foraida, Russell Ryan Kempker, Rachel Kyeyune, Eric L. Nuermberger, Janeway Granche, Sandy Nerette, Gustavo E. Velásquez, Melanie Goth, Cecilia Kanyama, Andrew Vernon, Jhoanna Roa, Elisa H. Ignatius, Linda J. Harrison, Susan E. Dorman, Austin Van Grack
article en
2 citations

Abstract

No abstract available for this paper.
TrialsVol. 26(1)
Johns Hopkins University (US), Emory University (US), Medical University of South Carolina (US), University of California, San Francisco (US), UCLA Health (US), TB Alliance (US), Cancer Research And Biostatistics (US), Social and Scientific Systems (United States) (US), South African Tuberculosis Vaccine Initiative (ZA), EsSALUD (PE), National Institute of Allergy and Infectious Diseases (US), Gheskio Centers (HT), Frontier Science & Technology Research Foundation, Inc. (US), Case Western Reserve University (US), Vanderbilt University Medical Center (US)
ACT Government, National Institutes of Health, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 9%
Tuberculosis Research and Epidemiology
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.